RLAY

Relay Therapeutics, Inc. Common Stock

7.42

USD

RLAY Earnings Reports

Positive Surprise Ratio

RLAY beat 13 of 22 last estimates.

59%

Next Report

Date of Next Report

Feb 24, 2026

Estimate for Q4 25 (Revenue/ EPS)

$5.06M

-$0.41

Implied change from Q3 25 (Revenue/ EPS)

-4.65%

Implied change from Q4 24 (Revenue/ EPS)

-8.89%

Relay Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, RLAY reported earnings of -0.43 USD per share (EPS) for Q3 25, missing the estimate of -0.42 USD, resulting in a -1.46% surprise. Revenue reached --, compared to an expected 186.52 thousand, with a -100.00% difference. The market reacted with a -7.35% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 13 analysts forecast an EPS of -0.41 USD, with revenue projected to reach 5.06 million USD, implying an decrease of -4.65% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Relay Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Relay Therapeutics, Inc. Common Stock reported EPS of -$0.43, missing estimates by -1.46%, and revenue of $0.00, -100% below expectations.

How did the market react to Relay Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -7.35%, changed from $6.53 before the earnings release to $6.05 the day after.

When is Relay Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 24, 2026.

What are the forecasts for Relay Therapeutics, Inc. Common Stock's next earnings report?

Based on 13 analysts, Relay Therapeutics, Inc. Common Stock is expected to report EPS of -$0.41 and revenue of $5.06M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.